Thank you for your interest in NTCA's guidance for healthcare providers considering use of the 3HP regimen for treatment of latent TB infection: Using the Isoniazid/Rifapentine Regimen to Treat Latent Tuberculosis Infection (LTBI).
Please note that we are collecting minimal contact information to conduct an evaluation to learn how this resource is being utilized and by whom.